Sato Fumitaka, Martinez Nicholas E, Stewart Elaine Cliburn, Omura Seiichi, Alexander J Steven, Tsunoda Ikuo
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71130, USA.
Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71130, USA.
BMC Neurol. 2015 Oct 24;15:219. doi: 10.1186/s12883-015-0478-y.
Although the precise mechanism of initial lesion development in multiple sclerosis (MS) remains unclear, two different neuropathological findings have been reported as a potential early pathology of MS: "microglial nodules" and "newly forming lesions", both of which contain neither T cell infiltration nor demyelination. In microglial nodules, damaged axons were associated with a small number of aggregated macrophages/microglia, while oligodendrocyte apoptosis was a characteristic in newly forming lesions. However, is the presence of "microglial nodules" and "oligodendrogliopathy" mutually exclusive? Might these two different observations be the same neuropathology (as proposed by the concept, "preactive lesions"), but interpreted differently based on the different theories of early MS lesion development, using different staining methods?
Since two studies are looking at two distinct aspects of early MS pathogenesis (one focused on axons and the other on oligodendrocytes), in a sense, one can say that these two studies are complementary. On the other hand, experimentally, Wallerian degeneration (WD) has been demonstrated to induce both microglial nodules and oligodendrocyte apoptosis in the central nervous system (CNS). Here, when encephalitogenic T cells are present in the periphery in both autoimmune and viral models of MS, induction of WD in the CNS has been shown to result in the recruitment of T cells along the degenerated tract, leading to demyelination (Inside-Out model). These experimental findings are consistent with early MS pathology described by both "microglial nodules" and "newly forming lesions".
The differences between the two neuropathological findings may be based on the preference of staining methods, where one group observed axonal and microglial pathology and the other observed oligodendrocyte apoptosis; a Janus face that is looked at from the two different sides.
尽管多发性硬化症(MS)初始病灶形成的确切机制仍不清楚,但已有两种不同的神经病理学发现被报道为MS潜在的早期病理学表现:“小胶质结节”和“新形成的病灶”,二者均无T细胞浸润和脱髓鞘现象。在小胶质结节中,受损轴突与少量聚集的巨噬细胞/小胶质细胞相关,而少突胶质细胞凋亡是新形成病灶的一个特征。然而,“小胶质结节”的存在与“少突胶质细胞病变”是否相互排斥?这两种不同的观察结果是否可能是相同的神经病理学表现(如“预激活病灶”概念所提出的),只是基于早期MS病灶发展的不同理论,使用不同的染色方法而有不同的解释?
由于两项研究关注的是早期MS发病机制的两个不同方面(一项关注轴突,另一项关注少突胶质细胞),从某种意义上说,可以认为这两项研究是互补的。另一方面,实验表明,华勒氏变性(WD)可在中枢神经系统(CNS)中诱导小胶质结节和少突胶质细胞凋亡。在这里,在MS的自身免疫和病毒模型中,当外周存在致脑炎性T细胞时,CNS中WD的诱导已被证明会导致T细胞沿变性束募集,从而导致脱髓鞘(由内而外模型)。这些实验结果与“小胶质结节”和“新形成的病灶”所描述的早期MS病理学一致。
这两种神经病理学发现之间的差异可能基于染色方法的偏好,其中一组观察到轴突和小胶质细胞病理学,另一组观察到少突胶质细胞凋亡;这是从两个不同侧面观察到的一张双面脸。